HighVista Biotechnology Opportunities Fund LP is a hedge fund based in Boston, Massachusetts. According to its most recent Form D, filed Jul 6, 2026, the fund has sold $453,188,582 of interests to 55 investors since its first sale in Jul 2020. The minimum investment it accepts from an outside investor is $500,000. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include HighVista Strategies LLC; HighVista GP VII Limited Partnership.
Performance
No verified returns have been reported for this fund. Hedge fund returns are not part of SEC filings; managers report them to HedgeMountain directly.
Is this your fund? Report your monthly returns · How performance works
- Total raised
- $453,188,582Cumulative sales reported on Form D
- Investors
- 55
- First sale
- Jul 1, 2020
- Minimum investment
- $500,000
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- HighVista Strategies LLC; HighVista GP VII Limited Partnership
- Latest Form D
- Jul 6, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and HedgeMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures
Size compared with every hedge fund
Raised more than 69% of the 472 hedge funds based in Massachusetts, and more than 80% of all 10,157 that report sales.
Other funds with the same team
More hedge funds in Boston
- DeltaTerra Partners LP - Series DT-2$20.0M
- Mercer FFTC US Fixed Income Investment Portfolio LLC$569M
- Mercer FFTC US Equity Investment Portfolio LLC$905M
- Mercer FFTC Non-US Equity Investment Portfolio LLC$457M
- Mercer FFTC Emerging Markets Equity Investment Portfolio LLC$203M
- Liminality Partners RV LP$169M